| Computer Errors in Primary
Care
Professor Tony
Avery,
Professor of
Primary Health Care
Division of Primary
Care
School of Community
Health Sciences
University of
Nottingham Medical School
Nottingham, UK
tony.avery@nottingham.ac.uk
I am going to be talking very briefly about a project
that we have done over the past year for the National Patient Safety Agency (NPSA) on computer errors in primary care.
First a little background, Nick was saying that general
practice is quite well computerised. There are over 30,000
GP's and there are only 30 practices that do not have a
computer and well over 95% of prescriptions are done by
computer. There are several suppliers (three main ones) of
computers for GP prescribing but all have certain minimal
requirement to satisfy funding rules e.g. computerised drug
interaction alerts. However the regulation so far have not had
a particularly strong safety bias. This is why I think we have
picked up quite a number of holes in the system.
Computers have considerable safety potential by providing
accurate information about patients and drugs at the point of
decision-making. They can provide decision-support,
intelligent hazard alerts, precautions, contraindications and
allergies. They can help with timely and appropriate
monitoring and they can also help with trapping errors. Here
is an example of a generic warning system and is one of
several screen shots that I will show today to give you an
idea of what the systems do.

The next clearly shows that the
patient has a history penicillin allergy, the next an interaction
alert between Viagra and Isosorbide Mononitrate.


This is a
major alert on the system that we use in our practice. All you
get is a hazard in yellow with three exclamation marks. The later
does not really hit you and does not distinguish between
different hazard levels and all you have to do is press the
escape key to cancel leaving no audit trail.

This example is a
slightly cleverer contraindication alert, picking up that the
patient has renal failure. You are trying to prescribe
Tetracycline but this is contraindicated and should be used
with caution in that situation. So some positives but there
are some problems. While computer systems have considerable
potential GP's and their staff may not know how to make best
use of them including safety features (which they may turn
off). Some of these systems allow the interactions alerts to
be turned off. GP's may override these alerts as we have found
- 25% of our sample overrode these alerts without proper
checking. In addition some of the desirable features may be
missing from some systems.
The first aim of our project was to identify some of the
most important safety issues regarding GP computer systems. We
also assessed the systems against these issues. We also wanted
to determine GP's knowledge and training needs in relation to
these systems. Finally we worked with stakeholders to produce
specifications for suppliers and for training practice staff.
One of the important aspects of this work is that it has come
at a very good time because the NHS is reprocuring I.T. We
have been able to recommend improvements to systems when they
can be taken up quickly.
How did we identify the most important safety issues? We
used two methods: stakeholder interviews usually with senior
people from suppliers, database manufacturers, medical defence
organisations, Royal Colleges and academics. We did
semi-structured interviews that were then transcribed and
analysed qualitatively. We also did a two-round Delphi
technique with experts in the field from a fairly wide range
of disciplines. They were asked to rate the importance of 55
statements that we had derived from the beginning of the
project. After two rounds 32 were judged to be either
important or very important by over 90% of the participants.
Now this slide summarises what came out of that:
1. The importance of computerised alerts.
2. Avoiding spurious alerts. GPs' get really fed up with
these and there is the risk of 'cry wolf syndrome' that may
cause a really important alert to be overridden.
3. Should not be possible to override the critical alerts
where it is possible to kill someone.
4. Audit trails.
5. Ensure the systems do not work unless the users actually
record data. For instance a patient with renal failure would
not have been flagged up unless the data had been entered that
the patient had renal failure.
6. The way patient safety information is presented. The
industry has grown up from very small beginnings. There is not
a Microsoft equivalent and the industry has not had a strong
safety focus. So not a lot of account has been given to the
most effective way of presenting safety information to elicit
the right response.
7. The need for practitioners to make the best use of
computerised systems to ensure that intended actions e.g.
patient referrals & monitoring are undertaken. The systems
have all got this functionality but we are not very good at
using it.
8. Training.
There were some of the key things coming out of the
beginning. We then wanted to condense all of this into some
test cases e.g. the systems had to recognise age in the
context of contraindications. So we developed vignettes e.g.
trying to prescribe aspirin to a child, which is
contraindicated. We then tested these out in a laboratory
setting with the four most commonly used systems. Two
independent testers did this and agreed that they had the same
results. We then tested these out in general practice to see
if we had the same results and also fed the results back to
the suppliers to check that they were happy that they had not
missed anything. They also agreed with our results. We are
going to publish in April.
Here are some of the key points with examples and then I am
going to show some screen shots.
1. Lack of alerts in relation to contraindications. I had
thought the problem was the database but found when talking to
First Databank (Europe) that the company's system could do
everything. The problem is that they do not have to do it and
it takes programmer time to make the links between the
database and the patients' recorded morbidities. So there are
already systems that have the potential functionality that we
need.
2. Spurious alerts.
3. Drug allergies warnings and I am going to give a very
stark example of that.
4. Prescribing drugs with similar names.
5. Lack of warning for methotrexate
6. Hidden alerts.
7. The ease with which alerts can be overridden with a
complete lack of an audit trail.
TA (to DB)
You look puzzled about that.
DB
We just have an audit trail for everything and we require
people to say why they override.
TA
But what is interesting about the issue of audit trails is
that we thought at the beginning that the GP's might be a
little worried about introducing audit trails. However through
interviews and the questionnaire we found that GP's were fine
with the idea and the in some ways audit trails can protect
you. If you prescribe a beta-blocker to an asthmatic patient
then there may be on balance good reasons for doing so. If the
patient suffers an adverse event then you do have a rationale
for the audited override. Otherwise the decision looks
out-of-the-blue.
So here are some examples.
This is an example of
prescribing aspirin to an eight year-old child. You will see
'no warnings present' because the system does not recognise
age when examining contraindications.

This one looks a complicated screen and is a prescription
of Microgynon- an oral contraceptive for women with a past
history of deep vein thrombosis and the pill is
contraindicated for this particular woman. This is one of the
systems where this information is deep in the underlying
database but the links are missing. You could click on one of
these six tabs here and look at all the possible things that
you ought to be looking at in terms of contraindications but
these are not really going to alert you. What you really want
is a warning to flash up and say 'hold on' this patient has a
history of deep vein thrombosis.

Now here is a frightening example of an allergy. Some
systems allow a doctor to code for an allergy and then find
that it does come up as a warning. You can see the recorded
history of an allergy on the screen. A GP prescribes
penicillin, presses the 'Enter key' and the prescription is
printed. If however the GP knows to record this under the
reactions & allergies part of the database then an adverse
reaction flashes up when the prescription is attempted. This
is a crazy situation that the system's supplier recognises and
GP's should not need to know the foibles of the system to get
the right alert - that is the job of the supplier.

I am trying to prescribe penicillin in this
next example. Now we
know that the computerise systems have completely eliminated
the problem of illegible prescriptions. I and any other GPs I
know of in the UK do not have to type out the full name of the
drug because the first three or four letters will produce a
drop-down menu. This is an example of drugs with similar
names. Here Penicillamine comes up instead of Penicillin and
is a highly toxic drug used rarely and then only for patients
with rheumatoid arthritis. What is worrying about this example
is that the dosage - 250 mg - is similar to that for treating
tonsillitis. After almost all talks I give to GP's one or two
come up and say that they have made that mistake. Now
sometimes this sort of mistake is picked up by pharmacists but
there are cases of patient deaths from this error. So this is
an example of design faults in computerised prescribing. This
particular system does default to the most common alert once
you have started to use it for a while.


The next is an example of dosage frequency warning.
Methotrexate is an immunosuppressive drug that is increasingly
being used in general practice under directions from secondary
care for conditions like rheumatoid arthritis. The important
point is that it is prescribed weekly and the major risk is to
prescribe this highly toxic drug daily. It is possible to do
this daily without an alert and what is particularly worrying
is that the default pack-size is 28, which may give the
impression that the drug is taken daily. One of the systems
has partially got round this by warning that accompanies an
intended prescription that this should normally be given
weekly.

Here is what I have called a hidden alert; in this example
Propalolol (beta-blocker) is given to an asthmatic patient.
Can anyone see the alert?

You have to click on these two very
visible buttons at the bottom of the screen and then the alert
comes up.

Now there is an issue about over-alerting people but
this is a contraindication from Committee for the Safety of
Medicine. My view is that there are some things that we need
to know and not be able to turn off or hide. If we are going
to override such an alert then we need to record a very good
reason for doing so.
Now to the final part of this whistle-stop tour; we wanted
to find out what GP's knew about the safety features of
computerised prescribing systems, what use they made of them
and their training needs. We developed a questionnaire from
interviews, sent this to GP's in two sites in England and got
a very acceptable 67% response rate. Very briefly, the key
finding is that there is very strong support for alerts of the
sort that I have just described. Many GP's are not fully aware
of the safety features on their systems. We discovered the
very dangerous situation in which 33% of GP's thought their
system had contraindication alerts when in fact we had found
that this particular system lacks them. Only 20% of GP's had
had any training on the safety features of their systems.
So to conclude my introduction to primary care before
subsequent discussion. What is the relevance of this work to
the Metanetwork Group? Many of the issues that we have
identified will be addressed as part of the national I.T.
programme. There are issues that do not benefit from large
research projects; the issues just need to be tackled.
Nevertheless there is considerable scope for thinking about
further work that could be done particularly from a
multidisciplinary perspective.
Questions
OH
To what extent is the research based on the theory of risk and
risk management?
TA
This was a very practical approach. We have a
multidisciplinary team that brainstormed seemingly important
ideas and we gained evidence from the early interviews.
OH
If the GP's had a very poor understanding of risk and risk
management then your concept of risk was based on that same
poor understanding of risk.
TA
We identified a practical solution to an identified problem.
Do you have any recommendations?
DB
I think this is fabulous. One comment: there should be a core
set of things that people should not be allowed to turn off.
Our experience is that sometimes doctors turn off all the drug
allergy alerts. How can that be right? There is a lot of
useful information to be gleaned from a study of the frequency
with which individual alerts are overridden and then what
happens to patients when this happens. We have some
fascinating results and I will talk about that later but we
found very high override rates for certain alerts but the
patients did just fine. In that instance the doctors were
probably right and we were probably over concerned about
warnings. We emphasise making the really bad things look very
distinct because we found the same override rates for minor
and very serious alerts.
BF
We share your concerned about overrides and want to share a
little story with you. We know a truck company owner who has
1,000 semitractor-trailors that go all over the West (USA).
When one of the drivers misses a delivery an automatic message
is sent to the owner who then phones the driver. This has
reduced insurance premiums considerably. I heard about this
story at the same time that I was helping a hospital introduce
a bar-code system. There were many overrides detected and
reported to the service manager but there was no follow up.
AJ
I have talked to people in the UK who have done either large
hospital systems or many single ward pilots (we have lots of
those going on). All agreed that there are many overrides and
the messages are not very good. However we do not seem to
getting very far in deciding a core set of key messages. If
doing this in primary care is difficult then secondary care is
much worse. So a warning about Aspirin and Warfarin is deemed
unnecessary in a Coronary Care Unit but definitely needed in
care-of-the-elderly ward. How do you define and get agreement
about a core set of messages?
DB
We are working very hard as a network to try to define a core
set. We plan to have a core set medication safety decision
support in all our information systems in all our hospitals.
We have a group that works on this task. There will be things
at the margins that people legitimately disagree about but
those are probably not the most important things. I am also
trying to galvanise support for a national repository of
shared knowledge in the US and there is no reason why this
should not be international. We have spent years arriving at a
set of drug warning interactions.
TA
We have done the same thing for the NPSA, a scoping exercise
using a two-stage Delphi process with group of 12 experts. We
found the process difficult because there is a very grey area
between interactions where there is very high quality evidence
and others where the evidence is very fragmentary.
DB
I agree and the evidence once you get to the granular level is
often lousy. We have a paper that is yet to be published in
which we looked at ISOL??? interactions in the hospital. About
70% of the people who get an ISOL (a commonly used antifungal)
have one or more serious drug-drug interactions. We looked at
a very large number of patients who were exposed to those
drugs that interacted and none of them had an adverse drug
event related to the interaction. This suggests to me that the
underlying evidence was just a few case reports.
TA
Looking in detail at the drug-related hospital admissions.
Drug interactions do not seem to be a major cause of
admissions although from a quality point of view it does not
seem to be a good idea to override warnings about
interactions.
SG
Picking up a point that David was making: there is an
apparently high override frequency and in a lot of cases that
might be perfectly reasonable behaviour. In principle
computers can track override frequencies and can first
indicate when these alerts are inappropriate but can also
indicate anomalous patterns of cancellations of alerts by a
user. So an extreme level (but not an acceptable level) could
be fed back to the user. Here the comparison would be with the
peer group override frequency.
DB
That has not yet been done yet but could be very valuable. We
have some instances where we almost always know we are right
to deliver a warning. This is not mostly about medications but
in other areas. We have looked at the distribution of
overrides by individual and some are very different from the
norm. In a few instances they were then interviewed by their
managers with good effect. This is something that we should do
on a larger scale.
TA
Are there computer systems in the States that allow
pharmacists to pick up errors almost instantaneously?
DB
Yes but we do not check on individuals regularly but in
principle it is possible to do this.
ENDS
|